AFP and hepatocellular carcinoma: Although similar results were obtained when using ELISA for assessment of AFP-L3% in the CHB and HCC groups, a significantly higher AFP-L3% was measured for HCC patients when using the microarray assay (5.72±2.98.2% vs. 15.76±4.65%, P = 0.045) (Figure 2B).